What question did this study set out to answer?

The research aims to explore an innovative gene therapy approach using ultrasound-enhanced CRISPR-curcumin nanoparticles for cancer treatment.

Ultrasound-Enhanced CRISPR–Curcumin Nanoparticles for Gene-Modulating Therapy in Metastatic Pulmonary Lesions

View Full Paper

Ask AI

Bookmark

Authors

Ultrasound-stimulated CRISPR-CuNPs demonstrate effective gene modulation in metastatic cancer, suggesting a novel therapeutic strategy.

The research aims to explore an innovative gene therapy approach using ultrasound-enhanced CRISPR-curcumin nanoparticles for cancer treatment.
Utilized ultrasound parameters to activate CRISPR-curcumin nanoparticles.
Targeted KRAS gene silencing with concurrent curcumin-induced activation of TP53 and PTEN.
Assessed the therapeutic effects on metastatic pulmonary cancer phenotypes.
Achieved synergistic suppression of metastatic cancer traits.
Demonstrated a non-radiotoxic platform for targeted gene therapy.
Indicated potential for long-term genomic stability, pending further studies.

Xu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark